Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 Diabetes
Status:
Completed
Trial end date:
2004-01-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe.
The aim of this trial is to investigate the safety and efficacy of insulin detemir combined
with oral anti-diabetic drugs (OADs) versus insulin NPH combined with oral anti-diabetic
drugs (OADs) in Type 2 mellitus not well controlled on current therapy on blood glucose
control.